Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hodgkin Disease | 95 | 2018 | 1378 | 5.670 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 96 | 2016 | 11742 | 2.080 |
Why?
|
Lymphoma, Non-Hodgkin | 47 | 2016 | 1374 | 1.500 |
Why?
|
Bleomycin | 38 | 2016 | 494 | 1.260 |
Why?
|
Doxorubicin | 58 | 2016 | 2224 | 1.190 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 33 | 2014 | 1405 | 1.180 |
Why?
|
Vincristine | 71 | 2016 | 1036 | 1.100 |
Why?
|
Lymphoma | 46 | 2008 | 1901 | 1.070 |
Why?
|
Vinblastine | 29 | 2014 | 488 | 1.010 |
Why?
|
Medical Oncology | 8 | 2016 | 2321 | 0.980 |
Why?
|
Prednisone | 66 | 2016 | 1563 | 0.830 |
Why?
|
Procarbazine | 39 | 2016 | 172 | 0.750 |
Why?
|
Mechlorethamine | 28 | 2016 | 129 | 0.700 |
Why?
|
Cyclophosphamide | 60 | 2016 | 2220 | 0.700 |
Why?
|
Dacarbazine | 18 | 2014 | 559 | 0.690 |
Why?
|
Salvage Therapy | 15 | 2010 | 1263 | 0.670 |
Why?
|
Leukemia, Myeloid | 35 | 1987 | 694 | 0.620 |
Why?
|
Methotrexate | 42 | 2016 | 1719 | 0.610 |
Why?
|
Immunoconjugates | 2 | 2018 | 953 | 0.590 |
Why?
|
Famous Persons | 1 | 2016 | 109 | 0.470 |
Why?
|
Radiotherapy | 8 | 2014 | 1498 | 0.470 |
Why?
|
Antineoplastic Agents | 60 | 2015 | 13642 | 0.430 |
Why?
|
Cytarabine | 13 | 2009 | 698 | 0.430 |
Why?
|
Bone Marrow Transplantation | 22 | 1997 | 2693 | 0.420 |
Why?
|
Leucovorin | 21 | 2008 | 643 | 0.420 |
Why?
|
Combined Modality Therapy | 36 | 2014 | 8527 | 0.420 |
Why?
|
Clinical Trials as Topic | 29 | 2016 | 8002 | 0.400 |
Why?
|
Mediastinal Neoplasms | 11 | 2011 | 401 | 0.400 |
Why?
|
Etoposide | 10 | 2014 | 634 | 0.400 |
Why?
|
History, 20th Century | 7 | 2016 | 2767 | 0.360 |
Why?
|
Hydroxamic Acids | 1 | 2012 | 481 | 0.330 |
Why?
|
Breast Neoplasms | 30 | 2016 | 21019 | 0.300 |
Why?
|
Immunologic Factors | 4 | 2009 | 1590 | 0.280 |
Why?
|
Hematopoietic Stem Cell Transplantation | 6 | 2012 | 5672 | 0.280 |
Why?
|
Disease-Free Survival | 18 | 2014 | 6815 | 0.280 |
Why?
|
Standard of Care | 1 | 2011 | 551 | 0.280 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2009 | 237 | 0.280 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 | 1994 | 686 | 0.270 |
Why?
|
Humans | 314 | 2022 | 761596 | 0.260 |
Why?
|
Neoplasm Staging | 41 | 2014 | 11120 | 0.260 |
Why?
|
Physicians | 2 | 2022 | 4591 | 0.250 |
Why?
|
History, 21st Century | 3 | 2016 | 1567 | 0.250 |
Why?
|
Remission Induction | 18 | 2011 | 2397 | 0.250 |
Why?
|
Survival Analysis | 25 | 2009 | 10090 | 0.250 |
Why?
|
Leukemia | 18 | 2006 | 1522 | 0.240 |
Why?
|
Prognosis | 59 | 2011 | 29629 | 0.230 |
Why?
|
Lymphocytes | 7 | 2009 | 2612 | 0.230 |
Why?
|
Hematopoietic Cell Growth Factors | 2 | 1994 | 98 | 0.220 |
Why?
|
Drug Administration Schedule | 20 | 2016 | 4853 | 0.220 |
Why?
|
Bone Marrow Diseases | 3 | 1994 | 233 | 0.210 |
Why?
|
Hematology | 1 | 2006 | 243 | 0.210 |
Why?
|
Societies, Medical | 3 | 2006 | 3905 | 0.190 |
Why?
|
Burkitt Lymphoma | 11 | 2006 | 335 | 0.190 |
Why?
|
Survival Rate | 18 | 2014 | 12723 | 0.180 |
Why?
|
Carmustine | 6 | 1985 | 138 | 0.180 |
Why?
|
Drug Evaluation | 16 | 1990 | 641 | 0.180 |
Why?
|
Fluorouracil | 12 | 2016 | 1642 | 0.180 |
Why?
|
Interdisciplinary Communication | 1 | 2006 | 931 | 0.180 |
Why?
|
Treatment Outcome | 31 | 2014 | 64685 | 0.180 |
Why?
|
Drug Therapy, Combination | 47 | 1983 | 6312 | 0.160 |
Why?
|
Melphalan | 7 | 1994 | 420 | 0.160 |
Why?
|
Blast Crisis | 2 | 1990 | 102 | 0.160 |
Why?
|
Hematologic Neoplasms | 1 | 2011 | 1896 | 0.160 |
Why?
|
Adult | 153 | 2012 | 221210 | 0.160 |
Why?
|
Amsacrine | 2 | 2016 | 19 | 0.150 |
Why?
|
Female | 168 | 2016 | 392705 | 0.150 |
Why?
|
Transplantation Conditioning | 3 | 2009 | 1590 | 0.150 |
Why?
|
Middle Aged | 143 | 2012 | 220921 | 0.140 |
Why?
|
Carcinoma, Small Cell | 4 | 1994 | 420 | 0.140 |
Why?
|
Neoplasms | 30 | 2015 | 22173 | 0.140 |
Why?
|
Dexamethasone | 12 | 2008 | 1948 | 0.140 |
Why?
|
Asparaginase | 11 | 1972 | 240 | 0.140 |
Why?
|
Remission, Spontaneous | 32 | 1979 | 384 | 0.130 |
Why?
|
Antibodies, Monoclonal | 9 | 2009 | 9177 | 0.130 |
Why?
|
Gallium Radioisotopes | 3 | 1997 | 195 | 0.130 |
Why?
|
Male | 153 | 2016 | 360846 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 13 | 2007 | 9280 | 0.130 |
Why?
|
Life Tables | 1 | 2016 | 364 | 0.130 |
Why?
|
Granulocyte Colony-Stimulating Factor | 4 | 2009 | 629 | 0.130 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2009 | 617 | 0.130 |
Why?
|
Alkylating Agents | 8 | 1989 | 133 | 0.130 |
Why?
|
Follow-Up Studies | 34 | 2011 | 39106 | 0.120 |
Why?
|
Podophyllotoxin | 3 | 1984 | 20 | 0.120 |
Why?
|
Leukemia, Lymphoid | 15 | 1987 | 310 | 0.120 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2016 | 297 | 0.120 |
Why?
|
Reed-Sternberg Cells | 1 | 1994 | 72 | 0.120 |
Why?
|
Prescription Fees | 1 | 2015 | 153 | 0.110 |
Why?
|
Transplantation, Autologous | 13 | 1994 | 2115 | 0.110 |
Why?
|
Italy | 1 | 2016 | 842 | 0.110 |
Why?
|
Blood Transfusion, Autologous | 1 | 1994 | 130 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 19 | 2007 | 10766 | 0.110 |
Why?
|
Bone Marrow | 29 | 1993 | 2911 | 0.110 |
Why?
|
Topotecan | 2 | 2006 | 132 | 0.110 |
Why?
|
Aged | 89 | 2012 | 169310 | 0.110 |
Why?
|
Patient Advocacy | 1 | 2015 | 360 | 0.110 |
Why?
|
Positron-Emission Tomography | 4 | 2014 | 6484 | 0.100 |
Why?
|
Chromosomes, Human, 21-22 and Y | 10 | 1985 | 45 | 0.100 |
Why?
|
Publishing | 1 | 2000 | 833 | 0.100 |
Why?
|
Gallium | 4 | 2004 | 28 | 0.100 |
Why?
|
Splenectomy | 10 | 1991 | 391 | 0.100 |
Why?
|
Abdominal Neoplasms | 4 | 1990 | 287 | 0.100 |
Why?
|
Pneumonia | 1 | 2003 | 2143 | 0.100 |
Why?
|
Therapeutic Human Experimentation | 1 | 1990 | 43 | 0.090 |
Why?
|
Neoplasm Metastasis | 21 | 1997 | 4915 | 0.090 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2011 | 694 | 0.090 |
Why?
|
Testicular Neoplasms | 9 | 1992 | 799 | 0.090 |
Why?
|
Filgrastim | 1 | 2009 | 132 | 0.080 |
Why?
|
Adolescent | 64 | 2011 | 88326 | 0.080 |
Why?
|
Antigens, Neoplasm | 4 | 1993 | 1993 | 0.080 |
Why?
|
Splenomegaly | 7 | 1990 | 189 | 0.080 |
Why?
|
Cisplatin | 8 | 2002 | 1652 | 0.080 |
Why?
|
Recurrence | 15 | 2007 | 8466 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1505 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 2000 | 1463 | 0.080 |
Why?
|
Research Subjects | 1 | 1990 | 249 | 0.080 |
Why?
|
Astrocytoma | 1 | 1993 | 775 | 0.080 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 1998 | 1551 | 0.080 |
Why?
|
Health Personnel | 1 | 2022 | 3335 | 0.080 |
Why?
|
Burnout, Professional | 2 | 2000 | 704 | 0.070 |
Why?
|
Time Factors | 38 | 2011 | 39969 | 0.070 |
Why?
|
Lung Diseases | 2 | 1991 | 1909 | 0.070 |
Why?
|
Radiotherapy Dosage | 10 | 1999 | 2898 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2002 | 5305 | 0.070 |
Why?
|
Transplantation, Homologous | 5 | 2008 | 4807 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 1999 | 3688 | 0.070 |
Why?
|
Drug Costs | 1 | 2015 | 1183 | 0.070 |
Why?
|
Arabinonucleosides | 1 | 2007 | 34 | 0.070 |
Why?
|
Patient Selection | 2 | 2007 | 4244 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 11 | 2014 | 20568 | 0.070 |
Why?
|
Deoxycytidine | 3 | 2011 | 877 | 0.070 |
Why?
|
Europe | 1 | 2014 | 3420 | 0.070 |
Why?
|
Busulfan | 9 | 1985 | 258 | 0.070 |
Why?
|
Research Support as Topic | 1 | 1990 | 697 | 0.070 |
Why?
|
Chromosome Aberrations | 10 | 1977 | 1768 | 0.070 |
Why?
|
Patient Participation | 1 | 2015 | 1445 | 0.070 |
Why?
|
Recombinant Proteins | 4 | 2009 | 6534 | 0.060 |
Why?
|
Lymphoma, Follicular | 2 | 2009 | 457 | 0.060 |
Why?
|
Mitoguazone | 2 | 1982 | 11 | 0.060 |
Why?
|
Technetium Tc 99m Medronate | 1 | 1985 | 131 | 0.060 |
Why?
|
Leukopenia | 6 | 1999 | 213 | 0.060 |
Why?
|
Interferons | 2 | 1987 | 706 | 0.060 |
Why?
|
Lymphoma, B-Cell | 2 | 2006 | 940 | 0.060 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2007 | 125 | 0.060 |
Why?
|
Cytogenetics | 4 | 1993 | 198 | 0.060 |
Why?
|
Pelvic Neoplasms | 2 | 1983 | 247 | 0.060 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2007 | 212 | 0.060 |
Why?
|
United States | 13 | 2016 | 72340 | 0.060 |
Why?
|
Guanidines | 2 | 1982 | 194 | 0.060 |
Why?
|
Thrombocytopenia | 8 | 2007 | 1182 | 0.060 |
Why?
|
Hormones | 2 | 1986 | 869 | 0.060 |
Why?
|
Lymphoma, Large-Cell, Immunoblastic | 2 | 2001 | 25 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1833 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2012 | 2009 | 0.060 |
Why?
|
Blood Transfusion | 3 | 1989 | 1301 | 0.060 |
Why?
|
Immunophenotyping | 2 | 2002 | 1869 | 0.060 |
Why?
|
Mannitol | 3 | 1975 | 180 | 0.050 |
Why?
|
Lymphoma, T-Cell | 1 | 2006 | 304 | 0.050 |
Why?
|
Anthraquinones | 1 | 1983 | 41 | 0.050 |
Why?
|
Antigens, CD | 2 | 1993 | 4001 | 0.050 |
Why?
|
Cancer Care Facilities | 1 | 2006 | 422 | 0.050 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 1986 | 410 | 0.050 |
Why?
|
Boronic Acids | 1 | 2007 | 915 | 0.050 |
Why?
|
Nitrogen Mustard Compounds | 8 | 1975 | 44 | 0.050 |
Why?
|
Lymph Nodes | 12 | 2002 | 3465 | 0.050 |
Why?
|
Zinostatin | 2 | 1979 | 7 | 0.050 |
Why?
|
Radiopharmaceuticals | 1 | 2012 | 2650 | 0.050 |
Why?
|
Aspartic Acid | 4 | 1980 | 576 | 0.050 |
Why?
|
North America | 3 | 2005 | 1276 | 0.050 |
Why?
|
Insurance, Health, Reimbursement | 2 | 1999 | 385 | 0.050 |
Why?
|
Retrospective Studies | 23 | 2010 | 80647 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2002 | 10212 | 0.050 |
Why?
|
Neoplastic Stem Cells | 2 | 1990 | 1351 | 0.050 |
Why?
|
Ovarian Neoplasms | 10 | 1989 | 4878 | 0.050 |
Why?
|
Sirolimus | 1 | 2008 | 1533 | 0.050 |
Why?
|
Lung Neoplasms | 12 | 2002 | 13381 | 0.050 |
Why?
|
Vomiting, Anticipatory | 1 | 2001 | 2 | 0.050 |
Why?
|
Pyrazines | 1 | 2007 | 1202 | 0.050 |
Why?
|
Brain Neoplasms | 6 | 1993 | 9032 | 0.050 |
Why?
|
Phosphonoacetic Acid | 1 | 1980 | 54 | 0.050 |
Why?
|
Actuarial Analysis | 5 | 1995 | 372 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 9 | 1983 | 2827 | 0.050 |
Why?
|
Tomography, Emission-Computed | 1 | 2004 | 1122 | 0.050 |
Why?
|
Lymphatic Metastasis | 9 | 1993 | 2915 | 0.040 |
Why?
|
Leukocyte Count | 9 | 1983 | 1596 | 0.040 |
Why?
|
Philadelphia Chromosome | 3 | 1993 | 117 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 5 | 1995 | 3397 | 0.040 |
Why?
|
Bone Neoplasms | 6 | 1985 | 2529 | 0.040 |
Why?
|
Diploidy | 3 | 1977 | 132 | 0.040 |
Why?
|
Hypercalcemia | 2 | 1974 | 423 | 0.040 |
Why?
|
Age Factors | 9 | 2002 | 18399 | 0.040 |
Why?
|
Organophosphorus Compounds | 1 | 1980 | 206 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2008 | 1600 | 0.040 |
Why?
|
Castration | 4 | 1982 | 151 | 0.040 |
Why?
|
Genes, p53 | 1 | 2002 | 712 | 0.040 |
Why?
|
Nausea | 3 | 2001 | 679 | 0.040 |
Why?
|
Neoplasms, Second Primary | 4 | 2009 | 1052 | 0.040 |
Why?
|
Asparagine | 6 | 1972 | 119 | 0.040 |
Why?
|
Infusions, Intravenous | 2 | 2003 | 2217 | 0.040 |
Why?
|
Splenic Artery | 1 | 1979 | 57 | 0.040 |
Why?
|
Mastectomy | 6 | 1986 | 1822 | 0.040 |
Why?
|
Neoplasms, Radiation-Induced | 4 | 1991 | 549 | 0.040 |
Why?
|
Radionuclide Imaging | 5 | 1996 | 1972 | 0.040 |
Why?
|
Anemia, Hemolytic | 1 | 1979 | 162 | 0.040 |
Why?
|
Nitrosourea Compounds | 6 | 1977 | 32 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 2 | 1979 | 678 | 0.040 |
Why?
|
Infusions, Parenteral | 3 | 1983 | 397 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2003 | 610 | 0.040 |
Why?
|
Conditioning, Classical | 1 | 2001 | 368 | 0.040 |
Why?
|
Glioma | 1 | 1993 | 3455 | 0.040 |
Why?
|
Diaphragm | 2 | 1990 | 351 | 0.040 |
Why?
|
Proportional Hazards Models | 4 | 2002 | 12463 | 0.040 |
Why?
|
Immunotoxins | 1 | 1998 | 175 | 0.040 |
Why?
|
Biopsy, Needle | 2 | 2002 | 1626 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 13 | 1987 | 3615 | 0.030 |
Why?
|
Adaptation, Psychological | 3 | 2000 | 2629 | 0.030 |
Why?
|
Immunotherapy | 3 | 2009 | 4652 | 0.030 |
Why?
|
Neutropenia | 3 | 2007 | 885 | 0.030 |
Why?
|
Drug Therapy | 1 | 1999 | 503 | 0.030 |
Why?
|
Adenocarcinoma | 8 | 1982 | 6345 | 0.030 |
Why?
|
Graft vs Host Disease | 1 | 2008 | 3029 | 0.030 |
Why?
|
B-Lymphocytes | 6 | 1989 | 4758 | 0.030 |
Why?
|
Selection Bias | 1 | 1997 | 359 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2008 | 4176 | 0.030 |
Why?
|
Drug Resistance | 6 | 1991 | 1596 | 0.030 |
Why?
|
Bone Marrow Examination | 6 | 1978 | 155 | 0.030 |
Why?
|
Child | 35 | 2002 | 80158 | 0.030 |
Why?
|
Central Nervous System Neoplasms | 1 | 2004 | 916 | 0.030 |
Why?
|
Histamine | 1 | 1977 | 499 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 1980 | 1515 | 0.030 |
Why?
|
Hematopoiesis | 4 | 1994 | 2050 | 0.030 |
Why?
|
Treatment Failure | 3 | 2009 | 2643 | 0.030 |
Why?
|
Hydroxyurea | 5 | 1976 | 284 | 0.030 |
Why?
|
Cerebellar Neoplasms | 1 | 1980 | 586 | 0.030 |
Why?
|
Pleural Neoplasms | 1 | 1980 | 609 | 0.030 |
Why?
|
Evaluation Studies as Topic | 6 | 1988 | 1625 | 0.030 |
Why?
|
Hemolysis | 2 | 1974 | 415 | 0.030 |
Why?
|
Radiography | 5 | 1991 | 6965 | 0.030 |
Why?
|
Quality of Life | 5 | 2001 | 13367 | 0.030 |
Why?
|
Thrombocytosis | 1 | 1974 | 89 | 0.030 |
Why?
|
Megestrol | 1 | 1993 | 9 | 0.030 |
Why?
|
Ligases | 3 | 1970 | 333 | 0.030 |
Why?
|
Thymidine | 2 | 1980 | 299 | 0.030 |
Why?
|
Leukocytosis | 1 | 1975 | 251 | 0.030 |
Why?
|
Radiation Dosage | 2 | 2002 | 1958 | 0.030 |
Why?
|
Erythrocytes | 3 | 1983 | 2413 | 0.030 |
Why?
|
Drug Synergism | 5 | 2009 | 1757 | 0.030 |
Why?
|
Myeloproliferative Disorders | 2 | 1981 | 613 | 0.030 |
Why?
|
Leukocytes | 6 | 1983 | 2026 | 0.030 |
Why?
|
Disease Progression | 3 | 2008 | 13510 | 0.030 |
Why?
|
Mammography | 2 | 2002 | 2430 | 0.030 |
Why?
|
Menopause | 4 | 1988 | 1646 | 0.030 |
Why?
|
Mesothelioma | 1 | 1980 | 807 | 0.030 |
Why?
|
Peritoneal Neoplasms | 1 | 1980 | 711 | 0.030 |
Why?
|
Young Adult | 5 | 2011 | 59260 | 0.030 |
Why?
|
Sick Role | 1 | 1994 | 229 | 0.030 |
Why?
|
Chlorambucil | 2 | 1989 | 42 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 4 | 1996 | 3514 | 0.030 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 1992 | 491 | 0.030 |
Why?
|
Antigens, Surface | 4 | 1985 | 1606 | 0.030 |
Why?
|
Aneuploidy | 3 | 1990 | 552 | 0.030 |
Why?
|
Choriocarcinoma | 4 | 1983 | 121 | 0.030 |
Why?
|
Spinal Cord Neoplasms | 2 | 1985 | 263 | 0.030 |
Why?
|
Antigens, CD20 | 2 | 2009 | 200 | 0.020 |
Why?
|
Adrenalectomy | 3 | 1980 | 346 | 0.020 |
Why?
|
Nitroso Compounds | 1 | 1971 | 71 | 0.020 |
Why?
|
Emergencies | 1 | 1978 | 1217 | 0.020 |
Why?
|
Spleen | 4 | 1987 | 2295 | 0.020 |
Why?
|
Malignant Carcinoid Syndrome | 1 | 1971 | 30 | 0.020 |
Why?
|
Benzoates | 1 | 1973 | 212 | 0.020 |
Why?
|
Hyperkalemia | 2 | 1974 | 233 | 0.020 |
Why?
|
Survivors | 2 | 2002 | 2371 | 0.020 |
Why?
|
Immunologic Techniques | 1 | 1991 | 212 | 0.020 |
Why?
|
Ultrasonography | 2 | 1983 | 5971 | 0.020 |
Why?
|
Estrogen Antagonists | 2 | 1982 | 150 | 0.020 |
Why?
|
Blood Cell Count | 5 | 1977 | 397 | 0.020 |
Why?
|
Prednisolone | 2 | 1989 | 326 | 0.020 |
Why?
|
Biomedical Research | 1 | 2006 | 3429 | 0.020 |
Why?
|
Erythropoiesis | 2 | 1985 | 683 | 0.020 |
Why?
|
Culture Techniques | 2 | 1970 | 531 | 0.020 |
Why?
|
Child, Preschool | 16 | 2002 | 42232 | 0.020 |
Why?
|
Glutamine | 2 | 1970 | 577 | 0.020 |
Why?
|
Meninges | 2 | 1975 | 198 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2004 | 14665 | 0.020 |
Why?
|
Estrogens | 2 | 1988 | 1522 | 0.020 |
Why?
|
Hypophysectomy | 2 | 1980 | 114 | 0.020 |
Why?
|
Neoplasms, Multiple Primary | 4 | 1991 | 592 | 0.020 |
Why?
|
Meningeal Neoplasms | 2 | 1983 | 1248 | 0.020 |
Why?
|
Time | 1 | 1991 | 546 | 0.020 |
Why?
|
Prospective Studies | 12 | 2012 | 54423 | 0.020 |
Why?
|
Aged, 80 and over | 6 | 2011 | 58984 | 0.020 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 1970 | 94 | 0.020 |
Why?
|
Androgens | 2 | 1988 | 1286 | 0.020 |
Why?
|
Rodent Diseases | 1 | 1969 | 53 | 0.020 |
Why?
|
Bone Diseases | 2 | 1971 | 418 | 0.020 |
Why?
|
Urea | 1 | 1971 | 443 | 0.020 |
Why?
|
Interferon-alpha | 2 | 2009 | 921 | 0.020 |
Why?
|
Leukemia, Experimental | 1 | 1969 | 225 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 1994 | 1078 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1704 | 0.020 |
Why?
|
Sulfhydryl Compounds | 1 | 1970 | 301 | 0.020 |
Why?
|
Kidney Neoplasms | 2 | 1982 | 4251 | 0.020 |
Why?
|
Laparotomy | 5 | 1995 | 457 | 0.020 |
Why?
|
Axilla | 2 | 1993 | 624 | 0.020 |
Why?
|
Retroperitoneal Neoplasms | 4 | 1988 | 333 | 0.020 |
Why?
|
Calcineurin | 1 | 2008 | 229 | 0.020 |
Why?
|
Floxuridine | 1 | 1967 | 44 | 0.020 |
Why?
|
Bone Marrow Cells | 6 | 1983 | 2417 | 0.020 |
Why?
|
Caregivers | 1 | 2000 | 2238 | 0.020 |
Why?
|
Heart | 1 | 1980 | 4404 | 0.020 |
Why?
|
Central Nervous System Diseases | 3 | 1990 | 520 | 0.020 |
Why?
|
Random Allocation | 2 | 2004 | 2395 | 0.020 |
Why?
|
Guinea Pigs | 1 | 1969 | 1310 | 0.020 |
Why?
|
Dysgerminoma | 2 | 1983 | 66 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9420 | 0.020 |
Why?
|
Liver Neoplasms | 6 | 1978 | 4317 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 1993 | 1668 | 0.020 |
Why?
|
Pulmonary Fibrosis | 3 | 1983 | 505 | 0.020 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 1967 | 133 | 0.020 |
Why?
|
Thioguanine | 3 | 1976 | 45 | 0.020 |
Why?
|
Anemia, Aplastic | 2 | 1983 | 230 | 0.020 |
Why?
|
Nucleosides | 1 | 1967 | 131 | 0.020 |
Why?
|
Serum Albumin | 2 | 1969 | 672 | 0.020 |
Why?
|
Acute Disease | 5 | 1990 | 7237 | 0.020 |
Why?
|
Receptors, Steroid | 1 | 1987 | 156 | 0.020 |
Why?
|
Lymphocyte Activation | 3 | 1989 | 5485 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2002 | 15843 | 0.020 |
Why?
|
Injections, Intravenous | 6 | 1975 | 1379 | 0.020 |
Why?
|
Phenotype | 4 | 1993 | 16592 | 0.020 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2006 | 70 | 0.020 |
Why?
|
Research | 1 | 1994 | 1982 | 0.020 |
Why?
|
Teratoma | 2 | 1983 | 404 | 0.020 |
Why?
|
Internship and Residency | 1 | 2006 | 5882 | 0.020 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 1985 | 64 | 0.020 |
Why?
|
Diethylstilbestrol | 1 | 1986 | 87 | 0.020 |
Why?
|
Flutamide | 1 | 1986 | 95 | 0.020 |
Why?
|
Microscopy, Electron | 3 | 1982 | 2561 | 0.020 |
Why?
|
Transplantation Chimera | 1 | 2008 | 594 | 0.020 |
Why?
|
Health Care Reform | 1 | 1994 | 1247 | 0.020 |
Why?
|
Dihydrotestosterone | 1 | 1986 | 195 | 0.020 |
Why?
|
Cell Line | 3 | 1994 | 15601 | 0.020 |
Why?
|
Receptors, Estrogen | 2 | 1986 | 2209 | 0.020 |
Why?
|
Prodrugs | 1 | 2007 | 261 | 0.010 |
Why?
|
Interferon Type I | 1 | 1989 | 562 | 0.010 |
Why?
|
Risk Factors | 5 | 2002 | 74213 | 0.010 |
Why?
|
Logistic Models | 2 | 1998 | 13255 | 0.010 |
Why?
|
Blood Preservation | 1 | 1985 | 169 | 0.010 |
Why?
|
Primary Myelofibrosis | 3 | 1975 | 209 | 0.010 |
Why?
|
Soft Tissue Neoplasms | 3 | 1983 | 1159 | 0.010 |
Why?
|
Freezing | 1 | 1985 | 311 | 0.010 |
Why?
|
T-Lymphocytes | 4 | 1986 | 10194 | 0.010 |
Why?
|
Megakaryocytes | 2 | 1985 | 567 | 0.010 |
Why?
|
Progestins | 1 | 1986 | 301 | 0.010 |
Why?
|
Hematologic Diseases | 3 | 1995 | 496 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 2 | 1978 | 2297 | 0.010 |
Why?
|
Blood Urea Nitrogen | 3 | 1973 | 186 | 0.010 |
Why?
|
Lymphatic Diseases | 1 | 1985 | 320 | 0.010 |
Why?
|
Cataract | 1 | 1969 | 832 | 0.010 |
Why?
|
Gastrointestinal Neoplasms | 3 | 1988 | 954 | 0.010 |
Why?
|
Tamoxifen | 1 | 1988 | 965 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2002 | 5314 | 0.010 |
Why?
|
Mitoxantrone | 1 | 1983 | 148 | 0.010 |
Why?
|
Leukemia, Radiation-Induced | 2 | 1985 | 39 | 0.010 |
Why?
|
Cerebrospinal Fluid | 1 | 1966 | 544 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 1986 | 11122 | 0.010 |
Why?
|
Escherichia coli | 5 | 1972 | 4217 | 0.010 |
Why?
|
Radioisotopes | 2 | 1974 | 499 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 3 | 1982 | 793 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 2002 | 228 | 0.010 |
Why?
|
Blood Platelets | 6 | 1977 | 2479 | 0.010 |
Why?
|
Intercellular Junctions | 1 | 1982 | 195 | 0.010 |
Why?
|
Calcium | 2 | 1991 | 5722 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 2007 | 1189 | 0.010 |
Why?
|
Complement System Proteins | 1 | 1984 | 735 | 0.010 |
Why?
|
Twins, Monozygotic | 2 | 1979 | 470 | 0.010 |
Why?
|
Vitamin B 12 | 2 | 1976 | 524 | 0.010 |
Why?
|
Cell Separation | 1 | 1987 | 1720 | 0.010 |
Why?
|
Predictive Value of Tests | 4 | 2002 | 15266 | 0.010 |
Why?
|
Lymphography | 4 | 1990 | 188 | 0.010 |
Why?
|
Probability | 3 | 1996 | 2477 | 0.010 |
Why?
|
Boston | 2 | 2008 | 9327 | 0.010 |
Why?
|
Platelet Count | 1 | 1983 | 781 | 0.010 |
Why?
|
Injections, Intraventricular | 1 | 1981 | 225 | 0.010 |
Why?
|
Carboxypeptidases | 1 | 1981 | 154 | 0.010 |
Why?
|
Cholesterol | 2 | 1969 | 2905 | 0.010 |
Why?
|
Sarcoma | 2 | 1983 | 1801 | 0.010 |
Why?
|
Aminoglutethimide | 1 | 1980 | 13 | 0.010 |
Why?
|
Cell Differentiation | 2 | 1990 | 11530 | 0.010 |
Why?
|
Diagnostic Errors | 2 | 1985 | 1265 | 0.010 |
Why?
|
Liver | 8 | 1979 | 7528 | 0.010 |
Why?
|
Glaucarubin | 1 | 1979 | 3 | 0.010 |
Why?
|
Risk Assessment | 1 | 2002 | 23996 | 0.010 |
Why?
|
Folic Acid | 1 | 1967 | 1323 | 0.010 |
Why?
|
Methods | 3 | 1988 | 1067 | 0.010 |
Why?
|
Stress, Psychological | 3 | 2001 | 4481 | 0.010 |
Why?
|
Creatinine | 2 | 1979 | 1899 | 0.010 |
Why?
|
Drug Combinations | 2 | 1977 | 2048 | 0.010 |
Why?
|
Oncogenes | 1 | 1985 | 1222 | 0.010 |
Why?
|
Maryland | 3 | 1977 | 277 | 0.010 |
Why?
|
Lymphoproliferative Disorders | 1 | 1983 | 531 | 0.010 |
Why?
|
Pyrans | 1 | 1979 | 49 | 0.010 |
Why?
|
Radiation Injuries | 2 | 1985 | 1189 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 1986 | 1079 | 0.010 |
Why?
|
Karyotyping | 3 | 1983 | 1171 | 0.010 |
Why?
|
Biopsy | 6 | 2002 | 6766 | 0.010 |
Why?
|
Cytokines | 1 | 1994 | 7396 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 1979 | 182 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1982 | 1762 | 0.010 |
Why?
|
Pilot Projects | 3 | 1995 | 8633 | 0.010 |
Why?
|
Carbon Isotopes | 2 | 1970 | 458 | 0.010 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 1979 | 186 | 0.010 |
Why?
|
Urogenital Neoplasms | 1 | 1980 | 131 | 0.010 |
Why?
|
Alopecia | 3 | 1983 | 412 | 0.010 |
Why?
|
Skin Neoplasms | 4 | 1976 | 5821 | 0.010 |
Why?
|
Drug Interactions | 1 | 1983 | 1416 | 0.010 |
Why?
|
Infection Control | 1 | 1985 | 982 | 0.010 |
Why?
|
Asbestos | 1 | 1980 | 251 | 0.010 |
Why?
|
Body Weight | 1 | 1989 | 4618 | 0.010 |
Why?
|
Immunoassay | 1 | 2002 | 745 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 6484 | 0.010 |
Why?
|
Head and Neck Neoplasms | 4 | 1981 | 2894 | 0.010 |
Why?
|
Lomustine | 1 | 1977 | 60 | 0.010 |
Why?
|
Neoplasms, Experimental | 2 | 1980 | 1229 | 0.010 |
Why?
|
Chronic Disease | 4 | 1975 | 9319 | 0.010 |
Why?
|
Streptozocin | 1 | 1977 | 194 | 0.010 |
Why?
|
Maytansine | 1 | 1978 | 86 | 0.010 |
Why?
|
Potassium | 2 | 1973 | 1311 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2003 | 2927 | 0.010 |
Why?
|
Mucous Membrane | 1 | 1980 | 659 | 0.010 |
Why?
|
Leukemia L1210 | 2 | 1975 | 44 | 0.010 |
Why?
|
Multiple Myeloma | 2 | 1993 | 5146 | 0.010 |
Why?
|
Animals | 12 | 1988 | 168475 | 0.010 |
Why?
|
Altretamine | 3 | 1985 | 11 | 0.010 |
Why?
|
Radiation Pneumonitis | 1 | 1997 | 102 | 0.010 |
Why?
|
Fluoxymesterone | 1 | 1996 | 12 | 0.010 |
Why?
|
Thiotepa | 1 | 1996 | 66 | 0.010 |
Why?
|
Cells, Cultured | 3 | 1982 | 18966 | 0.010 |
Why?
|
Regression Analysis | 1 | 1986 | 6345 | 0.010 |
Why?
|
Immune Tolerance | 1 | 1985 | 2302 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1986 | 2822 | 0.010 |
Why?
|
Cyclohexanes | 2 | 1974 | 152 | 0.010 |
Why?
|
Plasmapheresis | 1 | 1977 | 206 | 0.010 |
Why?
|
Mesna | 1 | 1995 | 62 | 0.010 |
Why?
|
Fibrosarcoma | 2 | 1975 | 309 | 0.010 |
Why?
|
Adjuvants, Pharmaceutic | 1 | 1975 | 48 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3713 | 0.010 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 1979 | 621 | 0.010 |
Why?
|
Palliative Care | 2 | 1988 | 3598 | 0.010 |
Why?
|
Oxazines | 1 | 1978 | 350 | 0.010 |
Why?
|
Medulloblastoma | 1 | 1981 | 678 | 0.010 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 1975 | 58 | 0.010 |
Why?
|
Alkaline Phosphatase | 2 | 1976 | 864 | 0.010 |
Why?
|
Adenoma, Islet Cell | 1 | 1975 | 72 | 0.010 |
Why?
|
Azauridine | 1 | 1974 | 2 | 0.010 |
Why?
|
Mitolactol | 1 | 1974 | 13 | 0.010 |
Why?
|
Agranulocytosis | 1 | 1975 | 97 | 0.010 |
Why?
|
Kidney | 3 | 1980 | 7048 | 0.010 |
Why?
|
Cystadenocarcinoma | 1 | 1974 | 54 | 0.010 |
Why?
|
Chromium Radioisotopes | 1 | 1974 | 34 | 0.010 |
Why?
|
Methemoglobin | 1 | 1974 | 25 | 0.010 |
Why?
|
Basophils | 1 | 1977 | 407 | 0.010 |
Why?
|
Osmotic Fragility | 1 | 1974 | 35 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 4 | 1981 | 4024 | 0.010 |
Why?
|
Transferrin | 2 | 1976 | 283 | 0.010 |
Why?
|
Death, Sudden | 2 | 1974 | 301 | 0.010 |
Why?
|
Melanoma | 4 | 1974 | 5709 | 0.010 |
Why?
|
Glucose | 1 | 1966 | 4347 | 0.010 |
Why?
|
Megestrol Acetate | 1 | 1993 | 18 | 0.010 |
Why?
|
Skin Diseases | 2 | 1980 | 1094 | 0.010 |
Why?
|
Hydrazones | 1 | 1974 | 103 | 0.010 |
Why?
|
Diagnosis, Differential | 4 | 1997 | 12973 | 0.010 |
Why?
|
BCG Vaccine | 1 | 1977 | 369 | 0.010 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 1 | 1974 | 94 | 0.010 |
Why?
|
Diarrhea | 1 | 1980 | 1318 | 0.010 |
Why?
|
Ferritins | 1 | 1976 | 598 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1975 | 1141 | 0.010 |
Why?
|
Phenylalanine | 1 | 1974 | 366 | 0.010 |
Why?
|
Half-Life | 1 | 1974 | 651 | 0.010 |
Why?
|
Pregnancy | 3 | 1982 | 29890 | 0.010 |
Why?
|
Skin Pigmentation | 1 | 1975 | 277 | 0.010 |
Why?
|
Daunorubicin | 1 | 1972 | 157 | 0.010 |
Why?
|
Ascitic Fluid | 1 | 1973 | 189 | 0.010 |
Why?
|
Infusion Pumps | 1 | 1993 | 163 | 0.010 |
Why?
|
Bromine | 1 | 1972 | 23 | 0.010 |
Why?
|
Blood Protein Disorders | 1 | 1971 | 8 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 1068 | 0.010 |
Why?
|
Glutathione | 1 | 1974 | 583 | 0.010 |
Why?
|
Anemia, Macrocytic | 1 | 1971 | 53 | 0.010 |
Why?
|
Personality Assessment | 1 | 1994 | 650 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1998 | 3415 | 0.010 |
Why?
|
Appetite | 1 | 1993 | 247 | 0.010 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 1971 | 93 | 0.010 |
Why?
|
Cause of Death | 1 | 2002 | 3683 | 0.010 |
Why?
|
Allopurinol | 1 | 1973 | 198 | 0.010 |
Why?
|
Esterases | 1 | 1971 | 98 | 0.010 |
Why?
|
Acid Phosphatase | 1 | 1971 | 139 | 0.010 |
Why?
|
Amenorrhea | 1 | 1975 | 483 | 0.010 |
Why?
|
Postoperative Period | 1 | 1996 | 1814 | 0.010 |
Why?
|
Cranial Irradiation | 1 | 1994 | 390 | 0.010 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 1992 | 189 | 0.010 |
Why?
|
Peroxidases | 1 | 1971 | 134 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 1974 | 730 | 0.010 |
Why?
|
Diplopia | 1 | 1972 | 214 | 0.010 |
Why?
|
Azaserine | 1 | 1970 | 8 | 0.010 |
Why?
|
Glycogen | 1 | 1971 | 251 | 0.010 |
Why?
|
beta-Aminoethyl Isothiourea | 1 | 1970 | 1 | 0.010 |
Why?
|
Chloromercuribenzoates | 1 | 1970 | 5 | 0.010 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 1974 | 517 | 0.010 |
Why?
|
Administration, Oral | 3 | 1975 | 4021 | 0.010 |
Why?
|
Puromycin | 1 | 1970 | 42 | 0.010 |
Why?
|
Psychological Tests | 1 | 1992 | 640 | 0.010 |
Why?
|
Self-Assessment | 1 | 1992 | 397 | 0.010 |
Why?
|
Social Adjustment | 1 | 1992 | 632 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1971 | 698 | 0.010 |
Why?
|
Bromides | 1 | 1969 | 22 | 0.010 |
Why?
|
Clinical Enzyme Tests | 1 | 1970 | 113 | 0.010 |
Why?
|
Chromatography | 1 | 1969 | 189 | 0.010 |
Why?
|
Azo Compounds | 1 | 1970 | 117 | 0.010 |
Why?
|
Adipose Tissue | 1 | 1982 | 3313 | 0.010 |
Why?
|
Sulfonic Acids | 1 | 1970 | 103 | 0.010 |
Why?
|
Hematocrit | 2 | 1987 | 623 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 1983 | 3080 | 0.010 |
Why?
|
Risk | 2 | 1996 | 9610 | 0.010 |
Why?
|
Motor Neurons | 1 | 1974 | 870 | 0.010 |
Why?
|
Lactates | 1 | 1970 | 405 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 1979 | 1459 | 0.010 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1989 | 317 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1974 | 3076 | 0.000 |
Why?
|
Bile Acids and Salts | 1 | 1971 | 393 | 0.000 |
Why?
|
Clone Cells | 1 | 1972 | 1659 | 0.000 |
Why?
|
Cohort Studies | 1 | 1991 | 41495 | 0.000 |
Why?
|
Infant | 3 | 1995 | 36193 | 0.000 |
Why?
|
Radiotherapy, Adjuvant | 1 | 1994 | 1784 | 0.000 |
Why?
|
Albumins | 1 | 1971 | 575 | 0.000 |
Why?
|
Sex Factors | 2 | 1998 | 10554 | 0.000 |
Why?
|
Oxidation-Reduction | 1 | 1974 | 2231 | 0.000 |
Why?
|
Colchicine | 1 | 1969 | 259 | 0.000 |
Why?
|
Splenic Neoplasms | 1 | 1988 | 94 | 0.000 |
Why?
|
Digestive System | 2 | 1979 | 244 | 0.000 |
Why?
|
Myocardium | 1 | 1980 | 4725 | 0.000 |
Why?
|
Fibrinogen | 1 | 1971 | 888 | 0.000 |
Why?
|
Phosphates | 1 | 1971 | 770 | 0.000 |
Why?
|
Lens, Crystalline | 1 | 1969 | 389 | 0.000 |
Why?
|
Carcinogens | 1 | 1969 | 452 | 0.000 |
Why?
|
Staining and Labeling | 1 | 1971 | 1085 | 0.000 |
Why?
|
Mice | 6 | 1982 | 81539 | 0.000 |
Why?
|
Neurologic Manifestations | 1 | 1966 | 19 | 0.000 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 1989 | 545 | 0.000 |
Why?
|
Skull | 1 | 1971 | 818 | 0.000 |
Why?
|
Physician-Patient Relations | 1 | 2000 | 3251 | 0.000 |
Why?
|
Immunoglobulins | 1 | 1989 | 852 | 0.000 |
Why?
|
Mitobronitol | 1 | 1985 | 3 | 0.000 |
Why?
|
Serotonin | 1 | 1971 | 1041 | 0.000 |
Why?
|
Laparoscopy | 3 | 1989 | 2036 | 0.000 |
Why?
|
Lipoproteins | 1 | 1971 | 881 | 0.000 |
Why?
|
Infant, Newborn, Diseases | 1 | 1971 | 589 | 0.000 |
Why?
|
Glioblastoma | 1 | 1981 | 3483 | 0.000 |
Why?
|
Immunocompromised Host | 1 | 1991 | 858 | 0.000 |
Why?
|
Teniposide | 1 | 1985 | 11 | 0.000 |
Why?
|
Interleukin-4 | 1 | 1989 | 1149 | 0.000 |
Why?
|
Fever | 2 | 1979 | 1618 | 0.000 |
Why?
|
Anemia | 1 | 1974 | 1509 | 0.000 |
Why?
|
Environmental Exposure | 1 | 1980 | 4485 | 0.000 |
Why?
|
South America | 2 | 1975 | 179 | 0.000 |
Why?
|
HIV Infections | 1 | 1991 | 17354 | 0.000 |
Why?
|
Mouth Neoplasms | 1 | 1970 | 596 | 0.000 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1972 | 1116 | 0.000 |
Why?
|
Uganda | 1 | 1969 | 1332 | 0.000 |
Why?
|
Activities of Daily Living | 1 | 1994 | 2421 | 0.000 |
Why?
|
Rats | 1 | 1980 | 23741 | 0.000 |
Why?
|
Cell Survival | 1 | 1974 | 5791 | 0.000 |
Why?
|
Cell Division | 1 | 1972 | 4465 | 0.000 |
Why?
|
Mesonephroma | 1 | 1983 | 21 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1995 | 5247 | 0.000 |
Why?
|
Socioeconomic Factors | 1 | 1998 | 7828 | 0.000 |
Why?
|
Amino Acids | 1 | 1970 | 1718 | 0.000 |
Why?
|
Lung | 1 | 1982 | 10002 | 0.000 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1985 | 242 | 0.000 |
Why?
|
Linear Models | 1 | 1993 | 5872 | 0.000 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 1974 | 1469 | 0.000 |
Why?
|
Weight Gain | 1 | 1993 | 2348 | 0.000 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 1985 | 882 | 0.000 |
Why?
|
Colony-Forming Units Assay | 1 | 1983 | 352 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1975 | 2539 | 0.000 |
Why?
|
Smoking | 1 | 1980 | 9053 | 0.000 |
Why?
|
Staphylococcal Infections | 1 | 1972 | 1407 | 0.000 |
Why?
|
Vinca Alkaloids | 2 | 1972 | 36 | 0.000 |
Why?
|
Gastrointestinal Diseases | 2 | 1981 | 1200 | 0.000 |
Why?
|
Spermatogenesis | 2 | 1974 | 259 | 0.000 |
Why?
|
Exudates and Transudates | 1 | 1982 | 174 | 0.000 |
Why?
|
Adrenal Cortex Hormones | 1 | 1971 | 1881 | 0.000 |
Why?
|
Organ Size | 1 | 1967 | 2254 | 0.000 |
Why?
|
Registries | 1 | 1998 | 8225 | 0.000 |
Why?
|
Neoplasm Invasiveness | 1 | 1989 | 3597 | 0.000 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1983 | 898 | 0.000 |
Why?
|
Diseases in Twins | 1 | 1963 | 446 | 0.000 |
Why?
|
Immunity, Cellular | 1 | 1987 | 1560 | 0.000 |
Why?
|
Autopsy | 2 | 1975 | 1009 | 0.000 |
Why?
|
Thymidine Phosphorylase | 1 | 1980 | 14 | 0.000 |
Why?
|
Cell Membrane | 1 | 1970 | 3687 | 0.000 |
Why?
|
Hepatomegaly | 1 | 1980 | 84 | 0.000 |
Why?
|
Quassins | 1 | 1979 | 6 | 0.000 |
Why?
|
Stem Cells | 1 | 1993 | 3524 | 0.000 |
Why?
|
Thymine | 1 | 1980 | 68 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 1993 | 12059 | 0.000 |
Why?
|
Lipids | 1 | 1971 | 3341 | 0.000 |
Why?
|
Thymidine Kinase | 1 | 1980 | 286 | 0.000 |
Why?
|
Interphase | 1 | 1979 | 228 | 0.000 |
Why?
|
Immunity | 2 | 1977 | 996 | 0.000 |
Why?
|
Pedigree | 2 | 1981 | 4542 | 0.000 |
Why?
|
Abdomen | 2 | 1975 | 1128 | 0.000 |
Why?
|
Acute Kidney Injury | 1 | 1971 | 1924 | 0.000 |
Why?
|
Carcinoma | 1 | 1970 | 2330 | 0.000 |
Why?
|
Uremia | 2 | 1969 | 201 | 0.000 |
Why?
|
Autoantibodies | 1 | 1987 | 2118 | 0.000 |
Why?
|
HLA Antigens | 1 | 1983 | 1328 | 0.000 |
Why?
|
Pancreatic Neoplasms | 1 | 1975 | 5368 | 0.000 |
Why?
|
Erythroblasts | 1 | 1977 | 142 | 0.000 |
Why?
|
Radiography, Thoracic | 1 | 1983 | 1302 | 0.000 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1983 | 1784 | 0.000 |
Why?
|
Graft Survival | 1 | 1987 | 3820 | 0.000 |
Why?
|
Blood Coagulation Disorders | 2 | 1969 | 350 | 0.000 |
Why?
|
Carcinoma 256, Walker | 1 | 1975 | 38 | 0.000 |
Why?
|
Indium | 1 | 1975 | 47 | 0.000 |
Why?
|
Lethal Dose 50 | 1 | 1975 | 72 | 0.000 |
Why?
|
Thallium | 1 | 1975 | 100 | 0.000 |
Why?
|
Kinetics | 2 | 1974 | 6374 | 0.000 |
Why?
|
Africa, Eastern | 1 | 1975 | 76 | 0.000 |
Why?
|
Maxillary Neoplasms | 1 | 1975 | 47 | 0.000 |
Why?
|
DNA Nucleotidyltransferases | 1 | 1975 | 175 | 0.000 |
Why?
|
Aluminum | 1 | 1975 | 152 | 0.000 |
Why?
|
Nervous System | 1 | 1978 | 545 | 0.000 |
Why?
|
Cardiovascular Diseases | 2 | 1995 | 15502 | 0.000 |
Why?
|
Killer Cells, Natural | 1 | 1983 | 2201 | 0.000 |
Why?
|
Mandibular Neoplasms | 1 | 1975 | 130 | 0.000 |
Why?
|
Disease Susceptibility | 1 | 1981 | 1787 | 0.000 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1975 | 411 | 0.000 |
Why?
|
Body Surface Area | 1 | 1974 | 197 | 0.000 |
Why?
|
Nitrates | 1 | 1975 | 263 | 0.000 |
Why?
|
Hypotension | 1 | 1979 | 879 | 0.000 |
Why?
|
Inclusion Bodies | 1 | 1975 | 281 | 0.000 |
Why?
|
Haplorhini | 1 | 1974 | 525 | 0.000 |
Why?
|
Hematopoietic System | 1 | 1973 | 110 | 0.000 |
Why?
|
Chromosome Disorders | 1 | 1976 | 497 | 0.000 |
Why?
|
Incidence | 1 | 1991 | 21355 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1983 | 5870 | 0.000 |
Why?
|
Macaca | 1 | 1974 | 410 | 0.000 |
Why?
|
Intestinal Neoplasms | 1 | 1975 | 314 | 0.000 |
Why?
|
Chlorides | 1 | 1975 | 665 | 0.000 |
Why?
|
Cobalt Isotopes | 1 | 1971 | 5 | 0.000 |
Why?
|
Electrophoresis, Disc | 1 | 1971 | 66 | 0.000 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 1971 | 81 | 0.000 |
Why?
|
Pancreatitis | 2 | 1969 | 1096 | 0.000 |
Why?
|
Amidohydrolases | 1 | 1972 | 159 | 0.000 |
Why?
|
Retroviridae | 1 | 1974 | 850 | 0.000 |
Why?
|
Chromatography, Ion Exchange | 1 | 1971 | 297 | 0.000 |
Why?
|
Crystallization | 1 | 1972 | 534 | 0.000 |
Why?
|
Erythrocyte Count | 1 | 1971 | 157 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 1970 | 7406 | 0.000 |
Why?
|
Hydrolysis | 1 | 1972 | 664 | 0.000 |
Why?
|
Hemoglobins | 1 | 1977 | 1526 | 0.000 |
Why?
|
Methylcellulose | 1 | 1970 | 34 | 0.000 |
Why?
|
Reticulocytes | 1 | 1971 | 289 | 0.000 |
Why?
|
Follicle Stimulating Hormone | 1 | 1973 | 726 | 0.000 |
Why?
|
Vitamin B 12 Deficiency | 1 | 1971 | 118 | 0.000 |
Why?
|
Infertility, Male | 1 | 1974 | 395 | 0.000 |
Why?
|
Luteinizing Hormone | 1 | 1973 | 820 | 0.000 |
Why?
|
Cytoplasm | 1 | 1975 | 1510 | 0.000 |
Why?
|
Abscess | 1 | 1974 | 606 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1981 | 2091 | 0.000 |
Why?
|
Vomiting | 1 | 1973 | 651 | 0.000 |
Why?
|
Osteomyelitis | 1 | 1974 | 407 | 0.000 |
Why?
|
Amylases | 1 | 1969 | 171 | 0.000 |
Why?
|
Genes, Recessive | 1 | 1971 | 623 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1996 | 36426 | 0.000 |
Why?
|
Intestine, Small | 1 | 1975 | 1206 | 0.000 |
Why?
|
Metabolic Diseases | 1 | 1975 | 683 | 0.000 |
Why?
|
Virus Diseases | 1 | 1974 | 718 | 0.000 |
Why?
|
Ovary | 1 | 1972 | 959 | 0.000 |
Why?
|
Iron | 1 | 1976 | 1793 | 0.000 |
Why?
|
Bilirubin | 1 | 1969 | 436 | 0.000 |
Why?
|
Hysterectomy | 1 | 1972 | 857 | 0.000 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1979 | 2020 | 0.000 |
Why?
|
Biological Transport | 1 | 1971 | 2091 | 0.000 |
Why?
|
Plasma | 1 | 1970 | 586 | 0.000 |
Why?
|
Cell Count | 1 | 1970 | 1835 | 0.000 |
Why?
|
Head | 1 | 1970 | 924 | 0.000 |
Why?
|
Nervous System Diseases | 1 | 1973 | 1667 | 0.000 |
Why?
|
Testosterone | 1 | 1973 | 2472 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 1963 | 11461 | 0.000 |
Why?
|
Drug Hypersensitivity | 1 | 1969 | 917 | 0.000 |
Why?
|
Brain Diseases | 1 | 1969 | 1546 | 0.000 |
Why?
|
Macrophages | 1 | 1975 | 5767 | 0.000 |
Why?
|
Protein Binding | 1 | 1971 | 9353 | 0.000 |
Why?
|
Inflammation | 1 | 1974 | 10774 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1976 | 15633 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1971 | 26202 | 0.000 |
Why?
|